Zoetis Inc. stock is up 11.29% since 30 days ago. The next earnings date is Feb 13, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 63.64% of the previous 10 December’s closed higher than November. In the last 10 Unusual Options Trades, there were 6 CALLs, 4 PUTs. 100% of analysts rate it a buy.
Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
---|---|---|---|---|---|
09 Nov 19:50 | 17 Nov, 2023 | 140.00 | 3 | ||
10 Nov 20:39 | 17 Jan, 2025 | 135.00 | 2 | ||
10 Nov 20:39 | 17 Jan, 2025 | 140.00 | 4 | ||
13 Nov 15:00 | 17 Nov, 2023 | 155.00 | 1793 | ||
13 Nov 15:01 | 17 Nov, 2023 | 155.00 | 1793 | ||
14 Nov 18:50 | 17 Jan, 2025 | 155.00 | 6 | ||
17 Nov 18:57 | 17 Nov, 2023 | 150.00 | 23 | ||
22 Nov 20:26 | 17 Jan, 2025 | 200.00 | 7 | ||
24 Nov 15:57 | 19 Jan, 2024 | 180.00 | 583 | ||
24 Nov 16:00 | 19 Jan, 2024 | 180.00 | 583 |
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts.